Cross-talk between the pineal gland and immune system

Chinese Medical Journal

Volumn 111, Issue 1, 1998, Pages 7-11

  Poon, A M S ^a,b   Liu, Z M ^a   Pang, S F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ANIMAL; HUMAN; IMMUNITY; PHYSIOLOGY; PINEAL BODY; REVIEW;

ANIMALS; HUMANS; IMMUNITY; MELATONIN; PINEAL GLAND;

EID: 0031598427     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Weigent DA, Blalock E. Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev 1987; 100:79.
2. Gupta D. An integrated communication network between the immune and neuroendocrine systems. In: Gupta D, Wollman HA, Ranke MB, eds. Neuroendocrinology: new frontiers. Tubingen: Brain Research Promotion, 1990: 265-285.
3. Felten DL, Cohen N, Ader R, et al. Central neural circuits involved in neural-immune interactions. In: Ader R, Felten DL, Cohen N, eds. Psychoimmunology. San Diego: Academic Press, 1991: 3-25.
4. Lissoni P, Morabito F, Esposti G, et al. A study on the thymus-pineal axis: interactions between thymic hormones and melatonin secretion. Acta Med Auxol 1988; 20:35.
5. Withyachumnarnkul B, Reiter RJ, Lerchl A, et al. Evidence that interferon-7 alters pineal metabolism both indirectly via sympathetic nerves and directly on pinealoeytes. Int J Biochem 1991; 12:1397.
6. Withyachumnarnkul B, Nonaka KO, Santana C, et al. Interferon-γ modulates melatonin production in rat pineal glands in organ culture. J Interferon Res 1990; 10:403.
7. Lissoni P, Barni S, Archili C, et al. Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer. Anticancer Res 1990; 10:753.
8. Miluc SM, Pitis M. Contributions a 1'etude de la correlation thymo-epiphysarie. Acta Endocrinol 1943; 9:13.
9. Jankovic BD, Isakovic K, Petrovic S. Effect of pinealectomy on immune reactions in the rat. Immunology 1970; 18:1.
10. Csaba G, Barath P. Morphological changes in the lung, thymus and the thyroid gland after postnatal extirpation of pineal body. Endocrinol Exp 1975; 9:59.
11. Csaba F, Bodoky M, Fischer J, et al. The effect of pinealectomy and thymectomy on the immune capacity of the rat. Experientia 1965; 22:168.
12. Kuci S, Becker J, Veit G, et al. Circadian variations in the immunomodulatory role of the pineal gland. Neuroendocrinol Lett 1988; 10:65.
13. Fernandes G, Yunis EJ, Halberg F. Circadian aspect of immune responses in the mouse. In: McGovem JP, Smolensky MH, Reinberg A, eds. Chronobiology in allergy and immunology. Illinois: Springfield, 1977: 233-249.
14. Fernandes G, Halberg F, Good APA. Circadian rhythm in T, B and natural killer cells. In: Smolensky MH, ed. Recent advances in the chronobiology of allergy and immunology. New York: Pergamon, 1980: 289-299.
15. Angeli A, Gatti G, Sartori ML, et al. Chronobiological aspects of neuroendocrine-immune network: regulation of human natural killer cell activity as a model. Chronobiologia 1992; 19:93.
16. Haus E, Lakatua DJ, Swoyer J, et al. Chronobiology in hematology and immunology. Am J Anat 1983: 168;467.
17. Maestroni GJM. The immunoneuroendocrine role of melatonin. J Pineal Res 1993; 14:1.
18. Sainz RM, Mayo JC, Uria H, et al. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J Pineal Res 1995; 19:178.
19. Pioli C, Caroleo MC, Nistico G, et al. Melatonin increases antigen presentation and amplifies specific and non-specific signals for T-cell proliferation. Int J Immunopharmacol 1993; 15:463.
20. Morrey KM, McLachlan JA, Serkin CD, et al. Activation of human monocytes by the pineal hormone melatonin. J Immunol 1994; 153:2671.
21. Maestroni GJM. T-helper-2 lymphocytes as a peripheral target of melatonin. J Pineal Res 1995; 18:84.
22. Artz EA, Fernandez-Castello S, Finocchiaro LME, et al. Immunomodulation by indoleamines: serotonin and melatonin action on DNA and interferon-γ synthesis by human peripheral blood mononuclear cells. J Clin Immunol 1988; 8:513.
23. Lewinski A, Zelazowsky A, Sewerynek E, et al. Melatonin-induced immunosuppression of human lymphocyte natural killer activity in vitro. J Pineal Res 1989; 7:153.
24. Persengiev SP, Kyurkchiev S. Selective effect of melatonin on the proliferation of lymphoid cells. Int J Biochem 1993; 3:441.
25. Di Stefano A, Paulesu L. Inhibitory effect of melatonin on production of IFN gamma or TNF alpha in peripheral blood mononuclear cells of some blood donors. J Pineal Res 1994; 17:164.
26. Poon AMS, Pang SF. Pineal melatonin-immune system interaction. In: Tang PL, Pang SF, Reiter RJ, eds. Melatonin: a universal photoperiodic signal with diverse actions. Front Hormones Research. 1996: 71-83.
27. Maestroni GJM, Conti A. Melatonin and the immune system. In: Touitou Y, Adrent J, Pevet P, eds. Melatonin and the pineal gland: from basic science to clinical application. Netherlands: Excerpta Medica, 1992: 295-302.
28. Maestroni GJM, Conti A. Melatonin in relation to the immune system. In: Yu HS, Reiter RJ, eds. Melatonin: biosynthesis, physiological effects and clinical applications. Boca Raton: CRC Press, 1992: 289-310.
29. Wajs E, Kutoh E, Gupta D. Melatonin affects propriomelanocortin gene expression in the immune organs of the rat. Eur J Endocrinol 1995; 133:754.
30. Moechegiani E, Bulian D, Santarelli L, et al. The zincmelatonin interrelationship: a working hypothesis. Ann NY Acad Sci 1994; 719:298.
31. Moechegiani E, Bulian D, Santarelli L, et al. The zinc pool is involved in the immune-reconstituting effect of melatonin inpinealectomized mice. J Pharmacol Exp Therapeut 1996; 277:1200.
32. Brainard GC, Watson-Whitmeyer M, Knobler RL, et al. Neuroendocrine regulation of immune parameters: photoperiod control of the spleen in Syrian hamsters. Ann NY Acad Sci 1988; 540:704.
33. Aoyama H, Mori W, Mori N. Anti-glucocoiticoid effects of melatonin in adult rats. Acta Pathol Jpn 1987; 37:1143.
34. Persengiev S, Patchev V, Velev B. Melatonin effects on thymus steroid receptors in the course of primary antibody responses: significance of circulating glucocorticoid levels. Int J Biochem 1991; 23:1487.
35. Persengiev S, Patches V, Velev B. Steroid hormone receptors in the thymus: a site of immunomodulatory action of melatonin. Int J Biochem 1991; 23:1483.
36. 125I] iodomelatonin binding sites in the duck thymus. Eur J Endocrinol 1994; 130:320.
37. Pierpaoli W, Yi C. The involvement of pineal gland and melatonin in immunity and aging: thymus mediated immuoreconstituting and antiviral activity of thyrotropin-releasing hormone. J Neuroimmunol 1990; 27:99.
38. Pang SF, Yuan H, Yu ZH, et al. Melatonin binding sites in the nervous and immune systems. In: Fraschini F, Reiter RJ, eds. Role of melatonin and pineal peptides in neuroimmunomodulation. New York: Plenum, 1991: 107-116.
39. 125I] Iodomelatonin binding sites in spleens of birds and mammals. Neurosci Lett 1991; 125:175.
40. Poon AMS, Liu ZM, Pang CS, et al. Evidence for a direct action of melatonin on the immune system. Biol Signals 1994; 3:107.
41. Niles LP. High affinity binding sites for melatonin in hamster spleen. Med Sci Res 1989; 17:179.
42. 125I] Iodomelatonin binding sites in spleens of guinea pigs. Life Sci 1992; 50:1719.
43. 125I] iodomelatonin by spleen membrane preparations of chicken. J Pineal Res 1992; 12:167.
44. 125L] labelled iodomelatonin in the duck thymus. Biol Signals 1992; 1:208.
45. 125I] Labelled iodomelatonin binding sites in the duck bursa of Fabricius: binding characteristics and diurnal variation. Neurosci Lett 1992; 146:163.
46. 125I] lodomelatonin-binding sites in the bursa of Fabricius of birds: binding characteristics, subcellular distribution, diurnal variations and age studies. J Endocrinol 1993; 138:51.
47. 125I] iodomelatonin binding sites in the pigeon spleen and modulation of binding by guanine nucleotides. J Pineal Res 1993; 14:169.
48. 125I] iodomelatonin by partially purified membranes of rat thymus. J Neuroimmunol 1993; 45:121.
49. 125I] iodomelatonin by rat splenocytes: characterization and its role on regulation of cyclic AMP production. J Neuroimmunol 1995; 57:171.
50. Lopez-Gonzalez MA, Calvo JR, Osuna C, et al. Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP. J Pineal Res 1992; 12:97.
51. Lopez-Gonzalez MA, Calvo JR, Osuna C, et al. Synergistic action of melatonin and vasoactive intestinal peptide in stimulating cyclic AMP production in human lymphocytes. J Pineal Res 1992; 12:174.
52. Lopez-Gonzalez MA, Calvo JR, Sequra JJ, et al. Characterization of melatonin binding sites in human peripheral blood neutrophils. Biotechnol Therapeut 1993; 4:253.
53. Reiter RJ. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review. Braz J Med Biol Res 1993; 26:1141.
54. Reiter RJ, Melchiorri D, Sewerynek E, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18:1.
55. Vijayalaxmi, Reiter RJ, Sewerynek E, et al. Marked reduction of radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Radiat Res 1995; 143:102.
56. Vijayalaxmi, Reiter RJ, Meltz ML. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat Res 1995; 346: 23.
57. Abe M, Reiter RJ, Orhii PB, et al. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 1994; 17:94.
58. Melchiorri D, Reiter RJ, Attia AM, et al. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1994; 56:83.
59. 125I] iodomelatonin binding sites in the chicken bursa of Fabricius and spleen. Neurosci Lett 1994; 173:167.
60. Calvo JR, Rafii-El-Irdrissi M, Pozo D, et al. Immunomodulatory role of melatonin: specific binding sites in human and rodent lymphoid cells. J Pineal Res 1995; 18:119.
61. 125I] iodomelatonin by rat thymus membranes during postnatal development. Immunol Lett 1993; 36:59.
62. 125I] iodomelatonin binding sites in the chicken (Gallus domesticus) kidney and spleen. Can J Physiol Pharmacol 1995; 73:685.
63. 125I] iodomelatonin binding sites in the guinea pig spleen. Neurosci Lett 1992; 146:41.
64. 125I] iodomelatonin binding sites in the guinea pig spleen by melatonin injection is dependent on the dose and period but not the time. Life Sci 1994; 54:1441.
65. 125I] iodomelatonin binding sites in the chicken spleen. Biol Signals 1994; 3:278.
66. 125I] iodomelatonin binding in the guinea pig spleen by guanine nucleotides and cations. Neuroendocrinology 1994; 59:156.
67. 125I] idomelatonin binding in the chicken lung, brain and kidney: the hypothesis of different subtypes of high affinity melatonin receptors. Biol Signals 1993; 2:27.
68. Conti A, Maestroni GJM. The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 1995; 19:103.
69. Lissoni P, Barni S, Crispino S, et al. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur J Cancer Clin Oncol 1989; 25:789.
70. Reiter RJ. The pineal gland and melatonin in relation to aging: a summary of the theories and data. Exp Gerontol 1995; 30: 199.